Difference between revisions of "Part:BBa K2796028"
Line 3: Line 3:
 
<partinfo>BBa_K2796028 short</partinfo>
 
<partinfo>BBa_K2796028 short</partinfo>
 
<ul>   
 
<ul>   
−
<li><b>Exosome booster</b> refers to hSDC4-T2A-STEAP3-P2A-NadB.We identified <b>STEAP3</b> (involved in exosomebiogenesis), syndecan-4(<b>SDC4</b> ; supports budding of endosomal membranes to form multivesicular bodies), and a fragment of L-aspartate oxidase  (<b>NadB</b>; possibly boosts cellular
+
<li><b>Exosome booster</b> refers to hSDC4-T2A-STEAP3-P2A-NadB.We identified <b>STEAP3</b> (involved in exosomebiogenesis), syndecan-4(<b>SDC4</b>; supports budding of endosomal membranes to form multivesicular bodies), and a fragment of L-aspartate oxidase  (<b>NadB</b>; possibly boosts cellular
 
metabolism by tuning up the citric acid cycle) as potential synthetic exosome production boosters. Combined expression of
 
metabolism by tuning up the citric acid cycle) as potential synthetic exosome production boosters. Combined expression of
 
these genes significantly increased exosome production.
 
these genes significantly increased exosome production.
 +
<ul>
 
(Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment; Ryosuke Kojima et al. 2008)</li>
 
(Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment; Ryosuke Kojima et al. 2008)</li>
  

Revision as of 14:13, 15 October 2018


Exosome booster

  • Exosome booster refers to hSDC4-T2A-STEAP3-P2A-NadB.We identified STEAP3 (involved in exosomebiogenesis), syndecan-4(SDC4; supports budding of endosomal membranes to form multivesicular bodies), and a fragment of L-aspartate oxidase (NadB; possibly boosts cellular metabolism by tuning up the citric acid cycle) as potential synthetic exosome production boosters. Combined expression of these genes significantly increased exosome production.
      (Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment; Ryosuke Kojima et al. 2008)

      Sequence and Features


      Assembly Compatibility:
      • 10
        COMPATIBLE WITH RFC[10]
      • 12
        COMPATIBLE WITH RFC[12]
      • 21
        INCOMPATIBLE WITH RFC[21]
        Illegal BglII site found at 192
        Illegal BglII site found at 1777
      • 23
        COMPATIBLE WITH RFC[23]
      • 25
        INCOMPATIBLE WITH RFC[25]
        Illegal AgeI site found at 2657
        Illegal AgeI site found at 3277
      • 1000
        INCOMPATIBLE WITH RFC[1000]
        Illegal SapI site found at 1367